Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 255

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1B
Chunk 255
---
RL Instance Document* 

    101.SCH 
     
    XBRL Taxonomy Extension Schema* 

    101.CAL 
     
    XBRL Taxonomy Extension Calculation Linkbase* 

    101.DEF 
     
    XBRL Taxonomy Extension Definition Linkbase* 

    101.LAB 
     
    XBRL Taxonomy Extension Label Linkbase* 

    101.PRE 
     
    XBRL Taxonomy Extension Presentation Linkbase* 

    104
     
    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) *

    *
     
    Provided herewith.
  
    **
     
    Furnished herewith.

68

SIGNATURES

Pursuant to the requirements of
Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

    Date: September 29, 2025
    LUNAI BIOWORKS INC.

    By: 
    /s/ David Weinstein

    David Weinstein

    Chief Executive Officer 

    (Principal Executive Officer) 

    By: 
    /s/ Nathen Fuentes

    Nathen Fuentes

     Chief Financial Officer 

    (Principal Financial and Accounting Officer) 

Pursuant to the requirements of
the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the
capacities and on the dates indicated.

    Signature
     
    Title
     
    Date

    /s/ David Weinstein
     
    Chief Executive Officer 
     
    September 29, 2025
  
    David Weinstein
     
    (Principal Executive Officer) 

    /s/ Nathen Fuentes
     
    Chief Financial Officer
     
    September 29, 2025
  
    Nathen Fuentes
     
    (Principal Financial and Accounting Officer)

    /s/ Douglas W. Calder
     
    Director 
     
    September 29, 2025
  
    Douglas W. Calder

    /s/ James A. McNulty 
     
    Director 
     
    September 29, 2025
  
    James A. McNulty

    /s/ Mark Collins, PhD. 
     
    Director 
     
    September